Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome.
Taylor AA, Bakris GL. Taylor AA, et al. Am J Med. 2010 Jul;123(7 Suppl 1):S21-6. doi: 10.1016/j.amjmed.2010.04.015. Am J Med. 2010. PMID: 20609696 Review.
The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).
Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S; SPRINT Study Research Group. Cho ME, et al. Among authors: taylor aa. J Clin Hypertens (Greenwich). 2017 Nov;19(11):1152-1161. doi: 10.1111/jch.13062. Epub 2017 Sep 3. J Clin Hypertens (Greenwich). 2017. PMID: 28866864 Clinical Trial.
Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes.
Yang EY, Brunner G, Dokainish H, Hartley CJ, Taffet G, Lakkis N, Taylor AA, Misra A, McCulloch ML, Morrisett JD, Virani SS, Ballantyne CM, Nagueh SF, Nambi V. Yang EY, et al. Among authors: taylor aa. J Am Soc Echocardiogr. 2013 Aug;26(8):901-909.e1. doi: 10.1016/j.echo.2013.04.014. Epub 2013 Jun 4. J Am Soc Echocardiogr. 2013. PMID: 23759168 Free PMC article.
Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension.
Taylor AA, Ragbir S. Taylor AA, et al. Patient Prefer Adherence. 2012;6:555-63. doi: 10.2147/PPA.S14764. Epub 2012 Aug 1. Patient Prefer Adherence. 2012. PMID: 22927748 Free PMC article.
Leadership message. ASH hypertension community outreach.
Taylor AA. Taylor AA. J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):527-8. doi: 10.1111/j.1751-7176.2010.00334.x. J Clin Hypertens (Greenwich). 2010. PMID: 20629817 No abstract available.
Angiotensin receptor blockers: pharmacology, efficacy, and safety.
Taylor AA, Siragy H, Nesbitt S. Taylor AA, et al. J Clin Hypertens (Greenwich). 2011 Sep;13(9):677-86. doi: 10.1111/j.1751-7176.2011.00518.x. Epub 2011 Jul 27. J Clin Hypertens (Greenwich). 2011. PMID: 21896150 Review.
Should two-drug initial therapy for hypertension be recommended for all patients?
Cowart JB, Taylor AA. Cowart JB, et al. Among authors: taylor aa. Curr Hypertens Rep. 2012 Aug;14(4):324-32. doi: 10.1007/s11906-012-0280-9. Curr Hypertens Rep. 2012. PMID: 22661332 Review.
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin A. Uresin Y, et al. Among authors: taylor aa. J Renin Angiotensin Aldosterone Syst. 2007 Dec;8(4):190-8. doi: 10.3317/jraas.2007.028. J Renin Angiotensin Aldosterone Syst. 2007. PMID: 18205098 Clinical Trial.
Clinical pharmacology of antihypertensive therapy.
Taylor AA, Pool JL. Taylor AA, et al. Semin Nephrol. 2005 Jul;25(4):215-26. doi: 10.1016/j.semnephrol.2005.02.006. Semin Nephrol. 2005. PMID: 16202694 Review.
Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.
Taylor AA, Shoheiber O. Taylor AA, et al. Congest Heart Fail. 2003 Nov-Dec;9(6):324-32. doi: 10.1111/j.1527-5299.2003.03269.x. Congest Heart Fail. 2003. PMID: 14688505
197 results
Jump to page